PT-141

sexual health

Bremelanotide

Mechanism of Action

A melanocortin receptor agonist that acts centrally in the brain to stimulate sexual desire. Unlike PDE5 inhibitors (Viagra), it works on the nervous system rather than blood flow. FDA-approved as Vyleesi.

Common Doses

500mcg

As needed, 45min beforesubcutaneous

1.75mg

As needed (Vyleesi dose)subcutaneous

Common Protocols

On-DemandAs needed

500-1750mcg subcutaneous 45 min before. Max 1 dose/24h, 8 doses/month.

Safety Notes

FDA-approved (Vyleesi). Common: nausea (40%), flushing, headache. Can cause skin darkening.

Legal Status

United States

FDA Approved

Australia

Schedule 4

United Kingdom

Prescription Only

Ready to track this peptide?

Start Experiment

This information is for educational purposes only. N1X does not recommend, endorse, or facilitate access to any substance. Always consult a qualified healthcare provider before starting any protocol.